Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Drops By 67.3%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCGet Free Report) was the recipient of a large decrease in short interest in December. As of December 31st, there was short interest totalling 6,500 shares, a decrease of 67.3% from the December 15th total of 19,900 shares. Approximately 1.2% of the shares of the company are short sold. Based on an average trading volume of 656,900 shares, the short-interest ratio is currently 0.0 days.

Institutional Investors Weigh In On China SXT Pharmaceuticals

Several large investors have recently modified their holdings of the stock. Acadian Asset Management LLC grew its stake in shares of China SXT Pharmaceuticals by 130.8% in the 1st quarter. Acadian Asset Management LLC now owns 105,039 shares of the company’s stock valued at $28,000 after purchasing an additional 59,519 shares during the period. Virtu Financial LLC bought a new stake in China SXT Pharmaceuticals during the 4th quarter worth approximately $48,000. Millennium Management LLC grew its position in China SXT Pharmaceuticals by 48.1% during the 4th quarter. Millennium Management LLC now owns 67,648 shares of the company’s stock worth $37,000 after acquiring an additional 21,963 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in China SXT Pharmaceuticals by 2,009.8% during the 1st quarter. Renaissance Technologies LLC now owns 451,500 shares of the company’s stock worth $126,000 after acquiring an additional 430,100 shares during the last quarter. 10.41% of the stock is currently owned by institutional investors.

China SXT Pharmaceuticals Trading Down 6.1 %

China SXT Pharmaceuticals stock traded down $0.13 during trading hours on Friday, hitting $2.00. The stock had a trading volume of 89,757 shares, compared to its average volume of 297,813. China SXT Pharmaceuticals has a fifty-two week low of $1.65 and a fifty-two week high of $17.00. The company has a 50-day moving average of $2.17 and a two-hundred day moving average of $3.27.

About China SXT Pharmaceuticals

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

See Also

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.